Aldosterone and cardiovascular disease: the heart of the matter.

Abstract

Aldosterone contributes to the endocrine basis of heart failure, and studies on cardiac aldosterone signaling have reinforced its value as a therapeutic target. Recent focus has shifted to new roles of aldosterone that appear to depend on coexisting pathologic stimuli, cell type, and disease etiology. This review evaluates recent advances in mechanisms underlying aldosterone-induced cardiac disease and highlights the interplay between aldosterone and Ca(2+)/calmodulin dependent protein kinase II, whose hyperactivity during heart failure contributes to disease progression. Increasing evidence implicates aldosterone in diastolic dysfunction, and there is a need to develop more targeted therapeutics such as aldosterone synthase inhibitors and molecularly specific antioxidants. Despite accumulating knowledge, many questions still persist and will likely dictate areas of future research.

• Authors: B Julie He, Mark E Anderson
• Journal: Trends in endocrinology and metabolism: TEM (Trends Endocrinol Metab) Vol. 24 Issue 1 Pg. 21-30 (Jan 2013) ISSN: 1879-3061 [Electronic] United States
• PMID: 23040074 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
• Copyright: Copyright © 2012 Elsevier Ltd. All rights reserved.

Chemical References

• Aldosterone
• Cytochrome P-450 CYP11B2
• Calcium-Calmodulin-Dependent Protein Kinase Type 2

Topics

• Aldosterone (metabolism)
• Animals
• Calcium-Calmodulin-Dependent Protein Kinase Type 2 (metabolism)
• Cardiovascular Diseases (metabolism)
• Cytochrome P-450 CYP11B2 (antagonists & inhibitors, metabolism)
• Heart Failure (metabolism)
• Humans